Home > News

Top 10 Biotech Startups Companies-2022

2022/5/27 17:16:32 Views:111

Original from: life sciences review

Biotech firms experienced a banner year in 2020.The COVID-19 pandemic highlighted the value of innovative medical solutions, leading to new opportunities for researchproduct approvaland funding

Biotechnology in today's world plays a major role in varied disciplines. It is a broad domain which comprises of a bundle of technologies that operates the natural idle things into modified outcomes with its increased potential and sustainable return of products. The goals of biotechnoloay are endless. it is been emploved for the benefit of humans and environment with correspondina development in scientific research and technological development

Developing a new product or altering an existing one through biotechnologies encounters various difficulties.Designing and successfully getting out the desired product in laboratory level is the first level of accomplishment.Next is to produce the product in pilot scale and to analyze statistical study on the industrial framework.On successful ielding and fabrication of the bio-modified product and their aimed application depends on, forecasting and governing the challenges of biotechnology marketing.

The list of Top 10 Biotech Startups Companies-2022

1. AtlasXomics

Commercializing a novel spatial biology tools platform-Deterministic Barcoding in Tissue for spatial-omics sequencing(DBiT-se)-that provides researchers and clinicians with unprecedented multi-omics maps of gene expression of tissue sections

By pinpointing specific changes in the varying cell groups of the central nervous system in neuro patients,DBiT-seq can help researchers better understand mechanisms of action and identify the safest and most effective approaches to drug discovery
-Ken Wang,CEO

2. ConcarloTherapeutics

Concarlo's innovative and patente d lpYa novel therapeutic peptide will be the first to address CDK2 resistance the first to target p27, and the first to inhibit both CDK4 and CDK2 at the same timeConcarlo targets a specific cellulan pathway to kill tumor cells rather t han iust slowing their proliferation.The company relies on the role of p27Kip1 - a vital "ON-OFF" switch that regulat es the activities of major cancer-related proteinsCDKCDK6and CDK2.

Concarlo Therapeutics is a woman-founded and run organization that is working towara revolutior hizing the metastatic breast cancer field"says DrStacy Blainthe companys Co-founder&ChiefScientific Officer

3. DelNova 
In 2016, Mary Gardner, the Founder and CEO,laid the foundation of DelNova.It is the only company in the industry  that is developing a feasible solution,ReViVox™,to address botulinum toxin type A complications following aesthetic and medical neurotoxin theranies Unlike others in the industry who have tried to resolve this issue bw focusing on the toxin,DelNova addresses these complications'outside of the neuron’Its novel solution, ReViVox acts as the perfect rescue product for all these complications without changing the toxin.DelNova is currently in the preclinical stage and is working toward collecting clinical data to validate the initial success of ReViVox. The company has already conducted a preliminarynon-clinical proof of conceptcollaborating with CRO partners to generate positive proof-of-concept data.

With Our Robust Solutions,We Offer Comfort And Assurance To Both Patients And Practitioners
-Mary Gardner, Founder and CEO

4. Gain Therapeutics

Gain Therapeutics is a preclinic cal biotechnology company focused on developing new medicines for protein misfolding diseases.

Gain The erapeutics Is The First Company To Successfully Combine Advance ements In Computational BiologyStructural Biology,And Superco mputers To Develop Drugs 

-Eric Richr man,cEO

5. Gator Bio

Gator Bio assists the R&D of th herapeutic drugs with a best-in-class platform-Biolayer Interferometry(BLl)-that detects biomolecular interactions for rapid auantitation.kinetic measurements. epitope binningand small molecule analysis. The BLI is a brilliant combination of engineering and sciences that results in revolutionaryanalytical  technologies with superior perfor mance and convenience at a fraction of the cost of traditional products.

The Gat or Prime and the Gator Plus platforms comprehensively meet the needs of all small a and medium biotech companies who are developing different therapeutics or biologics

6. lbex Biosciences

Developing gene therapies, a ntibodies, and regenerative platforms for treatment of cancer malaria and other diseases.

We are taking high-risk,high-reward approaches that are demonstrating activity agai inst cancer and other urgent conditions

-Norman LaicTOVidal de la CruzCSO&Co-CEOA.Murat CrociCo- Founder &Co-CEO,Saule Dairabayeva,Markets Manager,Michael J. Karlin,Co-Founder &CBO

Kineta is a Seattle-based clinical-stage bi otechnology company that sets itself on a mission to develop next-gen immunotherapies that transform patients’ lives. The company leverages its longstanding experience in immunology and in-depth expertise in innate immunity to develop first-in-class immunotherapies that address the challenges pertaining to current cancer therapiesBy developing immuno-oncology drugs that use the body's innate immune system to fight cancer they aim to improve the overall and long-term survival of cancer patients.

We believe that having a strong innate immune response will lead to a strong T-ce ill response; and together they can build a powerful shield against t umor cells 

-ShawnladonatoPh hD,CEO

Leukocare is a leading provider o f bioinformatics based drug product formulation and development of technologies for the biological functionalizatic on of medical devices, as well as the stabilization and protection of proteins. Leukocare stepped into the bioph harmaceutical sector as a product development company almost 20 years ago;. It pioneered the development of a coating for filter membrane,employing an antibody to reduce the activity of  neutrophil granulocytes.

We are h ighly specialized in stabilizing all kinds ofbiological molecules And we have a very stror ng bioinformatics based approach which we apply to different project resulting in an optimized formulation using less drug substance in less times

9. MAIA Biotechnology 

 MAIA Biotechnology is a targe ted therapy immune-oncology company focused on developing and commercializing  first-in-class drugs with novel mechanisms of action.

We envision testing THIO against as many tumor types and checkpoint com abinations as possible to realize its full potential to benefit a large population of pati ients
-VladVitoc,Founder and CEO

MOBILion Systemsstructures for lossless ion manipulation(SLIM)technology provides unprecedented capability to separate clinically relevant molecules for MS analysis It helps researchers drastically improve metabolic disease drug,and biomarker discoverypaving th he way for earlier disease detection more accurate diagnostics and reduced healthcare costs.Moreimportantl ySLIM provides a very long, 13 meter path length to allow for maximum ion separation. As a resultresearchers ca n use the arrival time as a fourth dimension of separation to accurately resolve isomers.

SLIM delivers cr itical quality attributes through high resolution reproducibility, and speed to advance biotherapeutics
-Julie SperrySenior Vice President Biopharma Business

Source: Top 10 Biotech Startups Companies-2022